Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2022Nature MicrobiologyOpen Access

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

View Full Paper
Ask AI
Bookmark
Share

Authors

CFCraig FenwickUniversity Hospital of LausannePTPriscilla TurelliÉcole Polytechnique Fédérale de LausanneDNDongchun NiShenzhen University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fenwick et al. (2022) studied this question.

synapsesocial.com/papers/6a8544f7e1eabc68e292941ahttps://doi.org/10.1038/s41564-022-01198-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Features and development of Coot2010 · 30,440 citations
  2. 2Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity2020 · 292 citations
  3. 3The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients2020 · 57 citations